C-C chemokine receptor type 4 antagonist Compound 22 ameliorates experimental autoimmune encephalomyelitis. Moriguchi K, Miyamoto K, Tanaka N, Ueno R, Nakayama T, Yoshie O, Kusunoki S J Neuroimmunol. 2016 Feb 15; 291:54-8. Epub 2015 Dec 24. PMID: 26857495. Abstract CommentRecommendBookmarkWatch